Intravenous anti- IgY-antibodies do not decrease pulmonary bacterial concentrations in a porcine model of ventilator-associated pneumonia
Ventilator associated pneumonia (VAP) caused by P. aeruginosa is a cause of morbidity and mortality in critically ill patients. The spread of pathogens with anti-microbial resistance mandates the investigation of novel therapies. Specific polyclonal anti- P. aeruginosa IgY-antibodies ( Pa- IgY) migh...
Main Authors: | A. Otterbeck, P. Skorup, K. Hanslin, A. Larsson, J. Stålberg, H. Hjelmqvist, M. Lipcsey |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-10-01
|
Series: | Innate Immunity |
Online Access: | https://doi.org/10.1177/17534259221114217 |
Similar Items
-
Enhanced bacterial clearance in early secondary sepsis in a porcine intensive care model
by: Frida Wilske, et al.
Published: (2023-02-01) -
IgY Antibodies as Biotherapeutics in Biomedicine
by: Diana León-Núñez, et al.
Published: (2022-09-01) -
Stability of Chicken IgY Antibodies Freeze-Dried in the Presence of Lactose, Sucrose and Threalose
by: Elin Nilsson, et al.
Published: (2007-01-01) -
IgY antibodies for the immunoprophylaxis and therapy of respiratory infections
by: Aymn Talat Abbas, et al.
Published: (2019-01-01) -
IgY antibodies: The promising potential to overcome antibiotic resistance
by: Sherif A. El-Kafrawy, et al.
Published: (2023-01-01)